相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。L-carnitine reduces hospital admissions in patients with hepatic encephalopathy
Joji Tani et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis
Mona Haj et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patients
Hisamitsu Miyaaki et al.
BMC GASTROENTEROLOGY (2020)
Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis
Shinya Sato et al.
BIOMEDICAL REPORTS (2020)
Can l-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
Atsushi Hiraoka et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis
Amir Abbasnezhad et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Sarcopenia in cirrhosis: from pathogenesis to interventions
Maryam Ebadi et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
Mark Hudson et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
Zhida Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Hepatic encephalopathy: Classification and treatment
Jasmohan Singh Bajaj
JOURNAL OF HEPATOLOGY (2018)
Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy
Steven L. Flamm
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial
Kazuyuki Suzuki et al.
HEPATOLOGY RESEARCH (2018)
L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis
Masaftugu Ohara et al.
HEPATOLOGY COMMUNICATIONS (2018)
Role of rifaximin in the treatment of hepatic encephalopathy
Jordi Sanchez-Delgado et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2016)
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
Duminda Suraweera et al.
GUT AND LIVER (2016)
Hepatic Encephalopathy
Eelco F. M. Wijdicks
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Covert and Overt Hepatic Encephalopathy: Diagnosis and Management
Kavish R. Patidar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
Hiroyuki Nakanishi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence
Steven L. Flamm
Therapeutic Advances in Gastroenterology (2011)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998
P Ferenci et al.
HEPATOLOGY (2002)
分享论文
